These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17005839)

  • 1. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
    Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 3. SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.
    Queenan AM; Torres-Viera C; Gold HS; Carmeli Y; Eliopoulos GM; Moellering RC; Quinn JP; Hindler J; Medeiros AA; Bush K
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3035-9. PubMed ID: 11036019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of an SME-2-producing Serratia marcescens isolate in Canada.
    Carrër A; Poirel L; Pitout JD; Church D; Nordmann P
    Int J Antimicrob Agents; 2008 Feb; 31(2):181-2. PubMed ID: 18083009
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    Lin X; Hu Q; Zhang R; Hu Y; Xu X; Lv H
    J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.
    Biagi M; Shajee A; Vialichka A; Jurkovic M; Tan X; Wenzler E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme.
    Gales AC; Biedenbach DJ; Winokur P; Hacek DM; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):125-7. PubMed ID: 11248526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6.
    Naas T; Vandel L; Sougakoff W; Livermore DM; Nordmann P
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1262-70. PubMed ID: 8092824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China.
    Zhang R; Zhou HW; Cai JC; Chen GX
    J Antimicrob Chemother; 2007 Mar; 59(3):574-6. PubMed ID: 17251347
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification, crystallization, and preliminary X-Ray diffraction analysis of the carbapenem-hydrolyzing class A beta-lactamase Sme-1 from Serratia marcescens.
    Sougakoff W; Jarlier V; Delettré J; Colloc'h N; L'Hermite G; Nordmann P; Naas T
    J Struct Biol; 1996; 116(2):313-6. PubMed ID: 8812987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from Serratia marcescens.
    Sougakoff W; L'Hermite G; Pernot L; Naas T; Guillet V; Nordmann P; Jarlier V; Delettré J
    Acta Crystallogr D Biol Crystallogr; 2002 Feb; 58(Pt 2):267-74. PubMed ID: 11807251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.
    Silva KE; Cayô R; Carvalhaes CG; Patussi Correia Sacchi F; Rodrigues-Costa F; Ramos da Silva AC; Croda J; Gales AC; Simionatto S
    J Clin Microbiol; 2015 Jul; 53(7):2324-8. PubMed ID: 25878341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.
    Bradford PA; Bratu S; Urban C; Visalli M; Mariano N; Landman D; Rahal JJ; Brooks S; Cebular S; Quale J
    Clin Infect Dis; 2004 Jul; 39(1):55-60. PubMed ID: 15206053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1.
    Mataseje LF; Boyd DA; Delport J; Hoang L; Imperial M; Lefebvre B; Kuhn M; Van Caeseele P; Willey BM; Mulvey MR
    J Antimicrob Chemother; 2014 Jul; 69(7):1825-9. PubMed ID: 24659751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    Hemarajata P; Amick T; Yang S; Gregson A; Holzmeyer C; Bush K; Humphries RM
    J Antimicrob Chemother; 2018 May; 73(5):1256-1262. PubMed ID: 29471486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of the carbapenem-hydrolyzing beta-lactamase gene blaOXA-48 in the environment in Morocco.
    Potron A; Poirel L; Bussy F; Nordmann P
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5413-4. PubMed ID: 21876064
    [No Abstract]   [Full Text] [Related]  

  • 19. Class A carbapenemases.
    Walther-Rasmussen J; Høiby N
    J Antimicrob Chemother; 2007 Sep; 60(3):470-82. PubMed ID: 17595289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.